Statistics for Day One Biopharmaceuticals, (id:7792 DAWN)

Valuation metrics

Market cap

1.38B

Enterprise value

789.52M

Trailing P/E (ttm)

-5.79

Forward P/E

-12.25

PEG ratio

-12.25

Price/Sales (ttm)

13.57

Price/Book (mrq)

2.49

Enterprise Value/Revenue

7.74

Enterprise Value/EBITDA

-3.84

Overview

Shares outstanding

100.85M

Float

69.39M

Shares short

18.02M

% Held by insiders

0.17%

% Held by institutions

0.93%

Average volume (10 days)

1.03M

Average volume (90 days)

Price summary

52-Week low

11.30

52-Week high

18.07

52-Week change

15.09%

Beta

-1.52

50-Day moving average

14.37

200-Day moving average

14.61

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-82.68%

Operating margin

31.61%

Operational effectiveness

Return on assets

-25.43%

Return on equity

-17.84%

Income statement

Revenue (ttm)

1.14

Revenue per share (ttm)

1.14

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-205,504,000.00

Net income to common (ttm)

-84,293,000.00

Diluted EPS (ttm)

-0.97

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

558.38M

Total cash per share (mrq)

5.54

Total debt (mrq)

2.62M

Total Debt/Equity (mrq)

0.47

Current ratio (mrq)

1.46K%

Book value per share (mrq)

5.51

Cash flow

Cash flow statement

-89,477,000.00

Levered free cash flow (LFCF)

-151,710,368.00